Cargando…
Efficacy and safety of therapies for advanced prostate cancer in Asia: Evidence from a systematic literature review
OBJECTIVES: Several therapies are available for the treatment of advanced/metastatic prostate cancer (PC). However, the systematic assessment of evidence pertaining to the use of these therapies in Asian patients is lacking. METHODS: A systematic literature review (SLR) was conducted using PubMed/Me...
Autores principales: | Saad, Marniza, Umbas, Rainy, Chiong, Edmund, Kanesvaran, Ravindran |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9666834/ https://www.ncbi.nlm.nih.gov/pubmed/36407784 http://dx.doi.org/10.1177/17588359221131525 |
Ejemplares similares
-
Novel hormonal therapies in the management of advanced prostate cancer: extrapolating Asian findings to Southeast Asia
por: Ong, Teng Aik, et al.
Publicado: (2023) -
The Protective Effect of Lycopene on Prostate Growth Inhibitory Efficacy by Decreasing Insulin Growth Factor-1 in Indonesian Human Prostate Cancer Cells
por: Tjahjodjati,, et al.
Publicado: (2020) -
Managing advanced prostate cancer in the Asia Pacific region: “Real‐world” application of Advanced Prostate Cancer Consensus Conference 2019 statements
por: Chiong, Edmund, et al.
Publicado: (2022) -
Outcomes and predictors of localized or locally-advanced prostate cancer treated by radiotherapy in Indonesia
por: Supit, Wempy, et al.
Publicado: (2013) -
ELIGANT: a Phase 4, interventional, safety study of leuprorelin acetate (ELIGARD(®)) in Asian men with prostate cancer
por: Malek, Rohan, et al.
Publicado: (2022)